Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJAlexander J. MullerJBJames B. DuHadawayPSPreston S. DonoverESErika Sutanto‐WardGCGeorge C. Prendergast
Lankenau Institute for Medical Research · Thomas Jefferson University
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,068
total citations
- FWCI
- 19.87
- Percentile
- 100%
- References
- 54
Citations per year
Authors
5- AJAlexander J. MullerCorresponding
- JBJames B. DuHadaway
Lankenau Institute for Medical Research
- PSPreston S. Donover
Lankenau Institute for Medical Research
- ESErika Sutanto‐Ward
Lankenau Institute for Medical Research
- GCGeorge C. Prendergast
Thomas Jefferson University, Lankenau Institute for Medical Research
Topics & keywords
Topics
Keywords
- Indoleamine 2,3-dioxygenase
- Immune system
- Cancer
- Cancer research
- Cancer cell
- Immunology
- Cytotoxic T cell
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.